Opioid Induced Constipation Drugs Market Size - By Drug Class (PAMORAs, Chloride channel-2 Activators, Laxatives, PPI, Anti-diarrheal), Prescription Type (Prescribed, OTC), Route of Administration – Global Forecast, 2024 – 2032
Report ID: GMI8483
|
Published Date: March 2024
|
Report Format: PDF
Download Free PDF
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 8
Tables & Figures: 306
Countries covered: 22
Pages: 180
Download Free PDF

Opioid Induced Constipation Drugs Market
Get a free sample of this reportGet a free sample of this report Opioid Induced Constipation Drugs Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Opioid Induced Constipation Drugs Market Size
Opioid Induced Constipation Drugs Market was valued at around USD 2.1 billion in 2023 and is expected to grow at 4.8% CAGR during 2024 to 2032, driven by the increasing use of opioids coupled with the rising prevalence of gastrointestinal disorders.
The increasing use of opioids has become a pervasive healthcare concern, with a rising number of patients relying on these potent pain relievers for various medical conditions. However, alongside the benefits of opioid medications, there is a growing recognition of their adverse effects, particularly opioid-induced constipation (OIC), requiring the use of drugs for the treatment of these adverse conditions.
Moreover, as the incidence of gastrointestinal disorders due to opioid use increases, there is a corresponding expansion of the patient pool actively seeking relief from opioid-induced constipation. This growing demographic of individuals experiencing gastrointestinal complications necessitates effective pharmaceutical interventions to alleviate constipation symptoms. OIC drugs, designed to specifically target constipation linked to opioid use, become essential in meeting the therapeutic needs of this expanding patient population, driving the market's growth.
Opioid induced constipation drugs refer to pharmaceutical agents specifically formulated to manage and alleviate constipation caused by the use of opioid medications. These drugs are designed to address the unique challenges of constipation associated with opioid use disorder, providing relief by promoting bowel movements and easing symptoms without compromising the analgesic effects of opioids.
Opioid Induced Constipation Drugs Market Trends
As the understanding of opioid-induced constipation evolves and the demand for more efficacious and targeted interventions rises, increased investment in R&D becomes a pivotal force shaping the trajectory of opioid induced constipation drugs industry.
Opioid Induced Constipation Drugs Market Analysis
The opioid induced constipation drugs industry by drug class is categorized into peripherally acting mu-opioid receptor agonists (PAMORAs), chloride channel-2 activators, laxatives, proton pump inhibitors, anti-diarrheal, and other drug classes. The peripherally acting mu-opioid receptor agonists (PAMORAs) segment was reached USD 706.3 million in 2023.
The opioid induced constipation drugs market by prescription type is categorized into prescribed drugs and over-the-counter (OTC) drugs. The prescribed drugs segment exceeded USD 1.3 billion in 2023.
Based on the route of administration, the opioid induced constipation drugs market is segmented into oral and injectable. The oral segment is anticipated to reach USD 2.4 billion by 2032.
The opioid induced constipation drugs market by distribution channel is categorized into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment dominates the market with a revenue around USD 1 billion in 2023.
North America opioid induced constipation drugs market size surpassed USD 858.2 million in 2023 and is predicted to witness substantial market growth over 2024-2032.
Opioid Induced Constipation Drugs Market Share
The opioid induced constipation drugs industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for opioid induced constipation drug manufacturers.
Opioid Induced Constipation Drugs Market Companies
Some of the eminent participants operating in the opioid induced constipation drugs industry include:
Opioid Induced Constipation Drugs Industry News
This opioid induced constipation drugs market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
Market, By Drug Class
Market, By Prescription Type
Market, By Route of Administration
Market, By Distribution Channel
The above information is provided for the following regions and countries: